Home » About Us » Our Leadership

Our Leadership

Catalent has attracted a world-class array of strategic and operational talent to lead us into cutting-edge innovation and reliable supply for our customers. Meet our Biologics Senior Leadership Team below.

BARRY LITTLEJOHNS

PRESIDENT

CORY LEWIS

Vice President,
General Manager
Drug Product

MICHAEL A. RILEY

Vice President,
General Manager
Drug Substance & Bioanalytical

KATHLEEN MUNSTER

Vice President, Quality

KAY SCHMIDT

Vice President,
Product Development

GREG BLECK, PH.D.

Global Head of R&D, Biologics

DAVID RABUKA, PH.D.

Global Head of R&D, Chemical Biology

BRIAN C. RILEY

Vice President,
Operations

KAREN RHYNER

Vice President,
Finance

BERNIE CLARK

Vice President,
Marketing & Strategy

ANDREW SANDFORD

Vice President,
Global Business Development
Drug Substance &
Biologics Analytical Services

KARIM ABDELKADER

Vice President, Business Development, Drug Product

VIC VINCI, PH.D.

Vice President, Product and Process Development

RYAN HAWKINS

General Manager,
Bloomington

GRAHAM BREARLEY, PH.D.

General Manager,
Madison

ERIC KUMMER

General Manager,
Brussels

REKHA PATEL

Director, Biologics Analytical Solutions

FRANK LI, PH.D.

Director,
Process Development

MARIA VIRGINIA POLI

Associate
General Counsel

BRENT BURKS

Global Director, Procurement

Advisory Board

Redwood Scientific Advisory Board

bars6